IDSA is urging school systems nationwide to use all available public health tools and strategies to prevent COVID-19 transmission in schools as teachers and students return to in-person learning.
IDSA is urging school systems nationwide to use all available public health tools and strategies to prevent COVID-19 transmission in schools as teachers and students return to in-person learning.
The FDA’s full approval of the Pfizer-BioNTech COVID-19 vaccine marks a pivotal milestone in the nation’s quest to control the effects of this pandemic. This approval is the culmination of intense, collaborative scientific research. The FDA’s announcement gives people who have not yet taken the vaccine additional assurance that this vaccine is safe and effective.
IDSA appreciates that HHS is planning to provide vaccinated people with a supplemental dose of vaccines if the FDA and CDC recommend a supplemental dose following a thorough and transparent evaluation of the evidence.
IDSA supports the FDA and CDC’s decision to authorize a supplemental vaccine dose for immunocompromised patients. This authorization will provide more protection for those who are at risk of serious COVID-19 illness and disease.
Increasing confidence in COVID-19 vaccines and uptake in these communities requires a creative, flexible and nimble approach that addresses the diverse concerns and barriers to vaccine access that people may have, according to a new article in Open Forum Infectious Diseases.
Pregnant individuals and those planning to become pregnant should feel confident in choosing vaccination to protect themselves, their infants, their families, and their communities.
A new Clinical Infectious Diseases supplement collects eight papers that have informed the scientific underpinning of essential nonbiological interventions used in the public health response to COVID-19.
As scientific and political leaders commemorate World Hepatitis Day, infectious diseases professionals call on policymakers to support the updated National Viral Hepatitis Strategic Plan that aims to eliminate viral hepatitis as a public health threat in the United States.
IDSA has awarded 24 institutions the designation of Antimicrobial Stewardship Center of Excellence, including the Cleveland Clinic Abu Dhabi, making it the first hospital outside of the United States to receive the distinction.
IDSA supports guidance announced today by CDC recommending mask wearing in indoor public settings for all individuals in communities with substantial or high COVID-19 transmission rates, regardless of COVID-19 vaccination status.
IDSA and HIVMA joined more than 50 health care professional organizations in calling for requiring COVID-19 vaccinations for all health care workers.
IDSA commends appropriators in the U.S. House of Representatives for much-needed resources to bolster the domestic and global fight against COVID-19 and HIV, antibiotic research and development, strengthen global health security, and combat the effects of the opioid crisis.